RM-50

The RM-50 is Remebot's cerebral hemorrhage surgical robot, featuring a 1-meter-tall frame with a robotic arm for minimally invasive neurosurgical procedures. It constructs 3D models of the brain to guide hematoma drainage through a 1mm-diameter hole. Received NMPA certification in 2022 and has been deployed at over 100 hospitals

Yes. RM-50 is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

RM-50 is made by Remebot, based in Beijing, China, founded in 2010.

1 verified deployment of RM-50 is on the DEPLOY registry, including at Beijing, China.

RM-50 is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable surgical robots to RM-50 include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

RM-50 and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. RM-50 has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, RM-50 ranks in roughly the top 87% of surgical models tracked by the registry.

RM-50 is at the production stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Production stage means high-volume manufacture and commercial-scale deployments are sustained.

RM-50 has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.